2025-03-01
2024-02-08
| Summary | |
|---|---|
| Cancer Type | Lung Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Western |
| Gender | F |
| Age | 60 |
| Pathology Diagnosis | Poorly differentiated malignant tumour T2a N0 M0 V0 R0. UPDATE- in view of the absence of an alternative primary site we regard this tumour as a poorly differentiated non-small cell carcinoma of the lung. |
| Biopsy Site | NA |
| Treatment History | NA |
| Pathology QC | Small round cell malignant tumor, and need to exclude malignant melanoma (P5, P7); IHC (P9): CK7(-),CD57(-),HMB45(-),CK5/6(-),P63(cytoplasmic staining 3+), TTF1(-), CK8/18(-), SYN (2+), EMA (2+). |
| Special Features | NA |
| Mouse Strain | Balb/c nu, MF-1 nu |
| TMA | TMA-HP-LU-017 |
| Viral Status in PDX | NA |
| Available In | CB_CN, CB-UK |
| RNA Seq | P4 |
| Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy